Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation
Clinical trial NCT01516567 · COMPLETED
Trial details
- NCT number
- NCT01516567
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2017-04-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.